Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018

Details for Mechanism ID: 17942
Country/Region: Côte d'Ivoire
Year: 2016
Main Partner: Abt Associates
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $1,600,001 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $60,657
Care: TB/HIV (HVTB) $20,646
Care: Pediatric Care and Support (PDCS) $7,857
Health Systems Strengthening (OHSS) $100,000
Testing: HIV Testing and Counseling (HVCT) $15,748
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $82,367
Treatment: Adult Treatment (HTXS) $1,282,390
Treatment: Pediatric Treatment (PDTX) $30,336
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 419
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 473
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 4,474
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 4,846
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 10,212
HTS_TST Service Delivery Point (Facility): Inpatient 2017 2,966
HTS_TST Service Delivery Point (Facility): Malnutrition facilities 2017 59
HTS_TST Service Delivery Point (Facility): Outpatient 2017 349
HTS_TST Service Delivery Point (Facility): PMTCT 2017 6,838
HTS_TST Sum of Aggregated Age/Sex <15 2017 892
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 9,320
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 10,212
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 13
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 32
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 180
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 201
PMTCT_ART Already on ART at beginning of current pregnancy 2017 104
PMTCT_ART New on ART 2017 147
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 6,920
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 145
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 78
PMTCT_EID Sum of Infant Age disaggregates 2017 223
PMTCT_STAT By: Known positives at entry 2017 104
PMTCT_STAT By: Number of new positives identified 2017 166
PMTCT_STAT Number of new ANC and L&D clients 2017 7,286
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 6,920
PMTCT_STAT Sum of Positives Status disaggregates 2017 270
TX_CURR Aggregated Age/Sex: <15 Female 2017 3
TX_CURR Aggregated Age/Sex: <15 Male 2017 3
TX_CURR Aggregated Age/Sex: 15+ Female 2017 460
TX_CURR Aggregated Age/Sex: 15+ Male 2017 250
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 716
TX_CURR Sum of Aggregated Age/Sex <15 2017 6
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 710
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 716
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 23
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 26
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 736
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 417
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,202
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,202